Taken together, evidence from neuroscience, human research, and clinical practice suggests meaningful overlap between obesity and addiction-related mechanisms. Lorenzo Leggio, MD, PhD, clinical director, National Institute on Drug Abuse, Bethesda, Md
in 2019 showed that the nuclear translocation of phosphorylated P65, the inhibition of IB kinase (IKK) within the NF-B signaling pathway, and phosphorylation of ERK, JNK, and P38 MAPK (i.e., activation of the MAPK signaling pathway) can control the production of IgE and IL-4 and inhibit inflammatory mediators in asthma
In a variety of cancers and chronic inflammatory diseases, SFN has been proven to have promising therapeutic effects [13, 14]
Kakegawa T, et al
What about Canada